Contact Us    855-RIA-PLAN (855-742-7526)

GSK: GlaxoSmithKline plc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 196,896.70
Enterprise Value ($M) n/a
Book Value ($M) 21,578.00
Book Value / Share 4.31
Price / Book n/a
NCAV ($M) -37,867.00
NCAV / Share -7.57
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.22

Liquidity (mrq)
Quick Ratio 0.53
Current Ratio 0.82

Balance Sheet (mrq) ($M)
Current Assets 17,566.00
Assets 77,011.00
Liabilities 55,433.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-29 13G/A BlackRock Inc. 7.50 0.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-09-24 596,348 4,112,095 14.50
2021-09-23 270,294 2,252,192 12.00
2021-09-22 387,821 4,606,196 8.42
2021-09-21 327,431 3,182,811 10.29
2021-09-20 363,547 3,803,821 9.56

(click for more detail)

(click for list of largest short owners)

Similar Companies
EBS – Emergent Biosolutions Inc ELAN – Elanco Animal Health Inc
ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units JNJ – Johnson & Johnson
LCI – Lannett Company, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: GlaxoSmithKline Pharmaceuticals Ltd





2018/07/06
> Back to All Posts